‘Right shoring’ API production in Europe
Pharmaceutical Technology
MARCH 22, 2023
Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Some large pharma companies have initiated indirect reshoring activities by increasing investment in new research and development and production units in their European facilities.
Let's personalize your content